Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Sonoma Pharmaceuticals, Inc. (SNOA) had Stock-Based Compensation of $0.06M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$6.41M |
|
$-0.33M |
|
$3.83M |
|
$2.58M |
|
$6.45M |
|
$-0.04M |
|
$-0.29M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.33M |
|
$-0.04M |
|
$-0.01M |
|
3.85M |
|
3.85M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$16.27M |
|
$0.29M |
|
$1.84M |
|
$18.11M |
|
$5.45M |
|
-- |
|
$6.07M |
|
$11.51M |
|
$6.59M |
|
$6.59M |
|
$6.59M |
|
4.79M |
|
| Cash Flow Statement Financials | |
$-0.65M |
|
$-0.00M |
|
$3.45M |
|
$2.40M |
|
$5.34M |
|
$2.94M |
|
|
Stock-Based Compensation |
$0.06M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.99 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
40.23% |
|
-0.62% |
|
-0.62% |
|
-- |
|
-5.15% |
|
-5.15% |
|
$-0.65M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
1.01 |
|
2.01 |
|
44.70 |
|
-5.00% |
|
-5.00% |
|
-1.82% |
|
-5.00% |
|
$1.38 |
|
$-0.17 |
|
$-0.17 |
|